These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5484024)

  • 41. [The gonadotropin, prolactin and sex steroid content of the blood from the inferior cavernous sinuses and the adrenal and ovarian veins of women with Itsenko-Cushing disease].
    Manusharova RA; Komissarenko IV; Iugrinov OG
    Vrach Delo; 1991 Mar; (3):71-4. PubMed ID: 2042357
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The effect of hormonal inhibition of the ovaries on ovarian steroid secretion].
    Kolarov P; Dokumov S; Spasov S; Stancheva M; Marovski S; Milanov S
    Akush Ginekol (Sofiia); 1972; 11(5):418-23. PubMed ID: 4651513
    [No Abstract]   [Full Text] [Related]  

  • 43. [Diagnosis of the syndrome of premature ovarian failure].
    Radwańska E
    Pol Tyg Lek; 1969 Sep; 24(39):1477-9. PubMed ID: 5365654
    [No Abstract]   [Full Text] [Related]  

  • 44. Clinical review: Identifying children at risk for polycystic ovary syndrome.
    Rosenfield RL
    J Clin Endocrinol Metab; 2007 Mar; 92(3):787-96. PubMed ID: 17179197
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Blood protein and steroid hormone levels in patients with the primary form of sclerocystic ovaries after surgical treatment].
    Dobrotina AF; Kachalina TS
    Akush Ginekol (Mosk); 1986 May; (5):28-30. PubMed ID: 2943175
    [No Abstract]   [Full Text] [Related]  

  • 46. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Etiopathogenesis of the polycystic ovary syndrome].
    Pelocchino AM; Montalenti D
    Minerva Med; 1973 Apr; 64(29):1530-42. PubMed ID: 4713748
    [No Abstract]   [Full Text] [Related]  

  • 48. Pituitary response to synthetic LH-RH in Stein-Leventhal syndrome and functional amenorrhea.
    Zárate A; Canales ES; De la Cruz A; Soria J; Schally AV
    Obstet Gynecol; 1973 Jun; 41(6):803-8. PubMed ID: 4575303
    [No Abstract]   [Full Text] [Related]  

  • 49. [The nyctohemeral rhythm of elimination of pituitary gonadotropins. II. Research in pathological conditions].
    Orlandi F; Abate G; Bernardi P; Ferramosca B
    Arch Patol Clin Med; 1966 Jun; 42(5):390-8. PubMed ID: 5989887
    [No Abstract]   [Full Text] [Related]  

  • 50. [Secretion of gonadotropins after administration of synthetic gonadotropin-releasing hormone (Gn-RH)].
    Rolandi E; Capitanio GL; Indiveri F; Azzolini A; De Cecco L
    Boll Soc Ital Biol Sper; 1973 Oct; 49(20):1190-2. PubMed ID: 4605938
    [No Abstract]   [Full Text] [Related]  

  • 51. [Evaluation of the determination of urinary gonadotropin levels in certain pathological syndromes in an internal clinic].
    KOSMALA U
    Pol Arch Med Wewn; 1961; 31():189-201. PubMed ID: 13753375
    [No Abstract]   [Full Text] [Related]  

  • 52. Polycystic ovary syndrome: an enigma awaiting solution.
    Schwartz M; Gindoff PR; Jewelewicz R
    Bull N Y Acad Med; 1987 Mar; 63(2):134-55. PubMed ID: 3472616
    [No Abstract]   [Full Text] [Related]  

  • 53. [Recent data concerning hypothalamic regulation of gonadotropin secretion from the anterior pituitary gland].
    Barry J
    Gynecologie; 1973; 24(2):173-7. PubMed ID: 4608001
    [No Abstract]   [Full Text] [Related]  

  • 54. [Value of the progesterone test in studying the etiology of the sclerocystic ovary (Stein-Leventhal) syndrome].
    Tychinskiĭ LI
    Akush Ginekol (Mosk); 1970 Feb; 46(2):39-44. PubMed ID: 5483571
    [No Abstract]   [Full Text] [Related]  

  • 55. The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome.
    Judd HL; Rigg LA; Anderson DC; Yen SS
    J Clin Endocrinol Metab; 1976 Aug; 43(2):347-55. PubMed ID: 950366
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Pathophysiology and therapy of the climateric syndrome].
    Kaiser R; Gördes W
    Med Klin; 1968 Jul; 63(30):1197-202. PubMed ID: 5719696
    [No Abstract]   [Full Text] [Related]  

  • 57. [The therapeutic effect of parlodel in the polycystic ovary syndrome].
    Soboleva EL; Komarov EK; Potin VV; Svechnikova FA
    Akush Ginekol (Mosk); 1990 Sep; (9):61-3. PubMed ID: 2278313
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Thyroxine, triiodothyronine and thyrotropic hormone levels in the blood of patients with sclerocystic ovary syndrome of central origin].
    Akopian SS; Mirimanova RP; Kazarian LS
    Akush Ginekol (Mosk); 1986 Feb; (2):54-7. PubMed ID: 2939752
    [No Abstract]   [Full Text] [Related]  

  • 59. [Short feedback control of gonadotropin secretion of the anterior pituitary gland].
    Igarashi M; Hirono M; Ibuki Y; Ehara Y; Mayuzumi R
    Saishin Igaku; 1969 May; 24(5):993-6. PubMed ID: 5812348
    [No Abstract]   [Full Text] [Related]  

  • 60. Polycystic ovarian disease: animal models.
    Mahajan DK
    Endocrinol Metab Clin North Am; 1988 Dec; 17(4):705-32. PubMed ID: 2973982
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.